2 recruiting, 1 completed. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Recruiting 2, Completed 1 |
Follow KarXT: new trials by email Literature Review of KarXT trials Research Report on KarXT
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Assess Safety and Tolerability of KarXT With Administration of Antiemetics in Healthy Volunteers KarXT, Trimethobenzamide, Ondansetron - Healthy Volunteers | Phase 4 | Recruiting | Karuna Therapeutics, Inc., a Bristol Myers Squibb company | 180 | 2026-09-03 | 2026-10-15 |
| A Study to Evaluate the Effect of KarXT on Urological Safety Xanomeline/trospium chloride - Schizophrenia | Phase 4 | Recruiting | Bristol-Myers Squibb | 60 | 2026-01-20 | 2026-11-10 |
| KarXT Concentrations in the Breast Milk and Plasma of Lactating Females Xanomeline/trospium chloride - Healthy Volunteers | Phase 4 | Completed | Karuna Therapeutics, Inc., a Bristol Myers Squibb company | 10 | 2026-01-09 | 2026-06-23 |
Nausea (1) · Schizophrenia (1) · Vomiting (1)
Karuna Therapeutics, Inc., a Bristol Myers Squibb company (2) · Bristol-Myers Squibb (1)
United States (3)